Zymeworks to receive $250 million under a royalty-backed note financing from Royalty Pharma with repayments due from 30% of worldwide tiered royalties on Ziihera until fully repaidZymeworks to retain ...
Rising Stroke Incidence, Expanding Rehabilitation Infrastructure, and Technology Adoption Accelerate Global Market GrowthAustin, United States, March 03, 2026 (GLOBE NEWSWIRE) -- Neurorehabilitation ...
Quarterly Revenue Grew 23.1% YoY and Organic Revenue Grew 11.3% YoYProduced Record Q4 Revenue of $1.70bln and Record Full Year Revenue of $7.0blnGenerated a Record ...